Mitotic kinesin inhibitors and methods of use thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S125000, C548S136000, C514S361000

Reexamination Certificate

active

07956073

ABSTRACT:
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.

REFERENCES:
patent: 2702803 (1955-02-01), Ainsworth
patent: 4782072 (1988-11-01), Stillings
patent: 4927822 (1990-05-01), Brown et al.
patent: 5668159 (1997-09-01), Jin et al.
patent: 5958957 (1999-09-01), Andersen et al.
patent: 5972937 (1999-10-01), Gaster et al.
patent: 5972978 (1999-10-01), Andersen et al.
patent: 6159938 (2000-12-01), Gyorkos et al.
patent: 6235762 (2001-05-01), Takasugi et al.
patent: 7115642 (2006-10-01), Singh et al.
patent: 7220745 (2007-05-01), Singh et al.
patent: 7326790 (2008-02-01), Singh et al.
patent: 7425636 (2008-09-01), Murakata et al.
patent: 7449486 (2008-11-01), Hans et al.
patent: 2002/0002193 (2002-01-01), Yu et al.
patent: 2003/0229054 (2003-12-01), Belliotti et al.
patent: 2004/0167188 (2004-08-01), Xin et al.
patent: 2004/0248950 (2004-12-01), Ishizuka et al.
patent: 2005/0004186 (2005-01-01), Barrett et al.
patent: 2005/0009877 (2005-01-01), Lu
patent: 2005/0070538 (2005-03-01), Cheng et al.
patent: 2005/0075375 (2005-04-01), Vourloumis et al.
patent: 2005/0119484 (2005-06-01), Breslin et al.
patent: 2007/0112044 (2007-05-01), Murakata et al.
patent: 2007/0155804 (2007-07-01), Murakata et al.
patent: 2007/0276017 (2007-11-01), Murakata et al.
patent: 2008/0153887 (2008-06-01), Cox et al.
patent: 0531906 (1993-03-01), None
patent: 1004241 (2000-05-01), None
patent: 2005-232016 (2005-09-01), None
patent: 2005232016 (2005-09-01), None
patent: 98/38177 (1998-09-01), None
patent: 01/56994 (2001-08-01), None
patent: 2004/111023 (2004-12-01), None
patent: 2005/092304 (2005-10-01), None
International Search Report for Co-Pending PCT Application Serial No. PCT/US2007/08246.
Bryn et al., “Chapter 11: Hydrates and Solvates” Solid-State Chemistry of Drugs, Second Edition, 1999, pp. 233-247.
Lala et al., “Role of Nitric Oxide in Tumor Progression: Lessons from Experimental Tumors” Cancer and Metastasis Reviews, 1998, 17(1), pp. 91-106.
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, 1999, vol. 286, pp. 537-537.
Askari et al., “Thiadiazoles and Thiadizolines, Part 1, Reaction of Thiourea and Ethylenethiourea with Chlorodiazabutadienes: A New Route to 4-amidino-1,3,4-thiadiazolines”; Database CAPLUS on STN, Chem. Abstr., Accession No. 1981:174996, Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry; 1981; pp. 360-365 abstract; vol. 2.
International Search Report related to corresponding PCT Application No. PCT/US2005/37305.
Office Action related to corresponding Chinese Patent Application No. 2005800436528.9.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mitotic kinesin inhibitors and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitotic kinesin inhibitors and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors and methods of use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2682917

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.